Cargando…
Development of bispecific antibodies in China: overview and prospects
A bispecific antibody (bsAb) can simultaneously bind two different epitopes or antigens, allowing for multiple mechanistic functions with synergistic effects. BsAbs have attracted significant scientific attentions and efforts towards their development as drugs for cancers. There are 21 bsAbs current...
Autores principales: | Zhang, Jing, Yi, Jizu, Zhou, Pengfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990247/ https://www.ncbi.nlm.nih.gov/pubmed/33928227 http://dx.doi.org/10.1093/abt/tbaa011 |
Ejemplares similares
-
Corrigendum to: Development of bispecific antibodies in China: overview and prospects
por: Zhang, Jing, et al.
Publicado: (2022) -
Development of a reporter gene method to measure the bioactivity of anti-CD38 × CD3 bispecific antibody
por: Xiong, Hui, et al.
Publicado: (2021) -
Development of Monoclonal Antibodies in China: Overview and Prospects
por: Zhang, Mao-Yu, et al.
Publicado: (2015) -
Engineering IgG-Like Bispecific Antibodies—An Overview
por: Krah, Simon, et al.
Publicado: (2018) -
Bioassay Development for Bispecific Antibodies—Challenges and Opportunities
por: Register, Ames C., et al.
Publicado: (2021)